Immunitybio, Inc.

IBRX·NASDAQ·$7.92Share Price as of 11/2·$8BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/04/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/23/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report10/14/26 8-KCurrent report08/04/26 8-KCurrent report07/30/26 8-KCurrent report06/10/26 8-KCurrent report05/18/26

Prospectuses and Registrations

424B5Prospectus supplement12/29/25 424B5Prospectus supplement07/28/25 S-8Registration of securities for employees06/23/25 424B5Prospectus supplement04/08/25 424B5Prospectus supplement12/12/24

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14CDefinitive information statement10/20/25 PRE 14CPRE 14C10/08/25 DEF 14ADefinitive proxy04/30/25

Ownership

Form 4Insider transaction10/06/26 Form 4Insider transaction10/06/26 144Proposed sale of securities10/05/26 144Proposed sale of securities10/02/26 SC 13D/ABeneficial ownership (amended)08/06/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders04/30/25 EFFECTRequest for effectiveness05/02/24 CORRESPCorrespondence with the SEC04/30/24 ARSAnnual report to shareholders04/29/24